J.P. Morgan Maintains Overweight on Illumina

J.P. Morgan is out with its report today on Illumina ILMN, maintaining Overweight. In its report, J.P. Morgan writes, "We see potential upside to 2011 and 2012 consensus estimates given conservative management guidance and the MiSeq launch; longer-term risks (e.g., NGS saturation, funding, and GWAS) are unlikely to slow near-term momentum; our rating remains Overweight." J.P. Morgan maintains an $80 PT on ILMN. Shares of ILMN closed Tuesday at $58.65.